---
title: "Energy Fuels President, CEO Purchased Shares Worth Over $967K"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292249608.md"
description: "Energy Fuels President and CEO Bhappu Ross R. purchased 74,000 common shares for $967,920 at an average price of $13.08 per share. Following this transaction, he directly owns 256,583 common shares. The purchase reflects multiple same-day acquisitions filed via SEC Form 4."
datetime: "2026-07-09T23:10:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292249608.md)
  - [en](https://longbridge.com/en/news/292249608.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292249608.md)
generator: "portal-rs"
---

# Energy Fuels President, CEO Purchased Shares Worth Over $967K

Bhappu Ross R., an officer serving as President and CEO, purchased shares of Energy Fuels. The transaction price represents an average purchase price of $13.08 per share. The total purchase amount was $967,920 for 74,000 common shares. Following the transaction, Bhappu Ross R. directly owns 256,583 common shares. The report notes the average price reflects multiple same-day purchases.

Reporter Name

Bhappu Ross R.

Relationship

President and CEO

Type

Purchase

Amount

$967,920

SEC Filing

Form 4

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [UUUU.US](https://longbridge.com/en/quote/UUUU.US.md)

## Related News & Research

- ["Heavy" Rare Earths Produced by Energy Fuels Qualified for Use by Largest Permanent Magnet Manufacturer in Japan | UUUU Stock News](https://longbridge.com/en/news/296338784.md)
- [DriveItAway to Suspend SEC Reporting, Files Form 15 to Deregister Common Stock](https://longbridge.com/en/news/296257472.md)
- [CFN Enterprises Delays Quarterly SEC Filing](https://longbridge.com/en/news/296151982.md)
- [Nocera flags prior financial statements as unreliable, files restatement in SEC amendment](https://longbridge.com/en/news/296145907.md)
- [Hansa Biopharma files confidential SEC draft for potential Nasdaq ADS listing](https://longbridge.com/en/news/296569331.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**